Gigtaz 4.5 Injection
Marketer
Primero Life sciences Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Gigtaz 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered exclusively by medical professionals, its dosage and frequency are determined by a physician based on individual health needs. Strict adherence to prescribed usage is crucial. Potential side effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor; dosage adjustments or alternative medications may be necessary. While generally safe under medical guidance, its use during pregnancy and breastfeeding should be carefully managed by a physician.
Primary Ingredients of Gigtaz 4.5 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Gigtaz 4.5 Injection
Infections caused by bacteria
Major Benefits of Gigtaz 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Gigtaz 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Gigtaz 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gigtaz 4.5 Injection works:
The injectable formulation, Gigtaz 4.5, merges Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby improving Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Gigtaz 4.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Gigtaz 4.5 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
The administration of Gigtaz 4.5 Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Gigtaz 4.5 Injection on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Gigtaz 4.5 Injection to individuals with impaired renal function. Dosage modification for Gigtaz 4.5 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Gigtaz 4.5 Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates that dosage modification may not be necessary for this patient population. However, physician consultation is recommended.
What if you forget to take Gigtaz 4.5 Injection :
Should you forget a scheduled Gigtaz 4.5 Injection, seek medical advice.
Facts to Know About Gigtaz 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |



